Rankia España Rankia Argentina Rankia Brasil Rankia Chile Rankia Colombia Rankia Czechia Rankia Deutschland Rankia France Rankia Indonesia Rankia Italia Rankia Magyarország Rankia México Rankia Netherlands Rankia Perú Rankia Polska Rankia Portugal Rankia Romania Rankia Türkiye Rankia United Kingdom Rankia USA
Acceder

Farmas USA

135K respuestas
Farmas USA
85 suscriptores
Farmas USA
Página
6.443 / 16.979
#51538

Re: Farmas USA

NVAX, JNJ J&J deal for Alios sets valuation benchmark for Novavax, says Piper Jaffray
Piper Jaffray sees Alios as a good comp for Novavax (NVAX) and believes Johnson & Johnson's (JNJ) purchase of Alios for $1.75B sets a benchmark for a potential Novavax acquisition that would provide "meaningful upside" from its current value. However, Piper thinks Novavax does not need a deal and may wait until after its Phase II RSV vaccine data is released next year to entertain any offers. The firm reiterate its Overweight rating and $10.50 price target on Novavax.

#51539

Re: Farmas USA

No pudo con la media y el cierre feo, a corto plazo pinta mas
irse abajo que arriba, espero no acertar.

#51541

Re: Farmas USA

Oktoberfest :) viva la birra

#51542

Re: Farmas USA

Se disparan las del ebola, primer caso en Dallas, de un paciente que venia de Liberia.

Guía Básica
Brokers destacados